2,307
Views
17
CrossRef citations to date
0
Altmetric
Articles

Long-term follow-up results of PTMC treated by ultrasound-guided radiofrequency ablation: a retrospective study

, ORCID Icon, , ORCID Icon, , & show all
Pages 1225-1232 | Received 24 May 2021, Accepted 29 Jul 2021, Published online: 17 Aug 2021

References

  • Howlader N, Krapcho M, Miller D, et al. SEER cancer statistics review, 1975–2016 [November 2018 SEER data submission posted to the SEER web site, April 9, 2020]. Bethesda, MD: National Cancer Institute; 2020. Available from: https://seer.cancer.gov/csr/1975_2016/
  • Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
  • Oda H, Miyauchi A, Ito Y, et al. Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery. Thyroid. 2016;26(1):150–155.
  • Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 2010;34(1):28–35.
  • Wang TS, Goffredo P, Sosa JA, et al. Papillary thyroid microcarcinoma: an over-treated malignancy? World J Surg. 2014;38(9):2297–2303.
  • Mauri G, Orsi F, Carriero S, et al. Image-guided thermal ablation as an alternative to surgery for papillary thyroid microcarcinoma: preliminary results of an Italian experience. Front Endocrinol. 2021;11:575152.
  • Guang Y, Luo Y, Zhang Y, et al. Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma. J Cancer Res Clin Oncol. 2017;143(8):1555–1562.
  • Ding M, Tang X, Cui D, et al. Clinical outcomes of ultrasound-guided radiofrequency ablation for the treatment of primary papillary thyroid microcarcinoma. Clin Radiol. 2019;74(9):712–717.
  • Cho SJ, Baek SM, Na DG, et al. Five-year follow-up results of thermal ablation for low-risk papillary thyroid microcarcinomas: systematic review and meta-analysis. Eur Radiol. 2021. DOI:https://doi.org/10.1007/s00330-021-07808-x
  • Miyauchi A. Clinical trials of active surveillance of papillary microcarcinoma of the thyroid. World J Surg. 2016;40(3):516–522.
  • Anatomical location classification of benign thyroid nodule and expert consensus on risk prevention and control of thermal ablation. Chinese J Med Ultrasonogr. 2020;17(01):6–10.
  • Mauri G, Pacella CM, Papini E, et al. Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria. Thyroid. 2019;29(5):611–618.
  • Endocrinology Society of Chinese Medical Association, Endocrinology Group of Chinese Medical Association Surgery Society, Head and Neck Tumor Professional Committee of China Anti-Cancer Association, Chinese Medical Association Nuclear Medicine Society. Guidelines for the diagnosis and treatment of thyroid nodules and differentiated thyroid cancer. Int J Clin Endocrinol Metab. 2012;4(10):779–797.
  • Mazzaferri EL. Management of low-risk differentiated thyroid cancer. Endocr Pract. 2007;13(5):498–512.
  • Li YJ, Wang YZ, Yi ZB, et al. Comparison of completion thyroidectomy and primary total surgery for differentiated thyroid cancer: a meta-analysis. Oncol Res Treat. 2015;38(10):528–531.
  • Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid NODULES-2016 UPDATE. Endocr Pract. 2016;22(5):622–639.
  • Haugen BR. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: what is new and what has changed? Cancer. 2017;123(3):372–381.
  • Min Y, Wang X, Chen H, et al. Thermal ablation for papillary thyroid microcarcinoma: how far we have come? Cancer Manag Res. 2020;12:13369–13379.
  • Mauri G, Cova L, Ierace T, et al. Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc Intervent Radiol. 2016;39(7):1023–1030.
  • Kim J, Yoo WS, Park YJ, et al. Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology. 2015;276(3):909–918.
  • Lim HK, Cho SJ, Baek JH, et al. Erratum: US-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: efficacy and safety in a large population. Korean J Radiol. 2020;21(4):510.
  • Nam-Goong IS, Kim HY, Gong G, et al. Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol. 2004;60(1):21–28.
  • Grebe SK, Hay ID. Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am. 1996;5(1):43–63.
  • Scheumann GF, Gimm O, Wegener G, et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg. 1994;18(4):559–568.
  • Chow SM, Law SC, Chan JK, et al. Papillary microcarcinoma of the thyroid-prognostic significance of lymph node metastasis and multifocality. Cancer. 2003;98(1):31–40.
  • Qubain SW, Nakano S, Baba M, et al. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery. 2002;131(3):249–256.
  • Hwang HS, Orloff LA. Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope. 2011;121(3):487–491.
  • Lee MC, Kim MJ, Choi HS, et al. Postoperative thyroid-stimulating hormone levels did not affect recurrence after thyroid lobectomy in patients with papillary thyroid cancer. Endocrinol Metab. 2019;34(2):150–157.
  • Li YJ, Wang YZ, Yi ZB, et al. Comparison of completion thyroidectomy and primary total surgery for differentiated thyroid cancer: a meta-analysis. Oncol Res Treat. 2015;38(10):528–531.
  • Kim JH, Baek JH, Lim HK, et al. 2017 Thyroid radiofrequency ablation guideline: Korean society of thyroid radiology. Korean J Radiol. 2018;19(4):632–655.
  • Robenshtok E, Fish S, Bach A, et al. Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients. J Clin Endocrinol Metab. 97(8):2706–2713.
  • Kim JH, Baek JH, Sung JY, et al. Radiofrequency ablation of low-risk small papillary thyroidcarcinoma: preliminary results for patients ineligible for surgery. Int J Hyperthermia. 2017;33(2):212–219.
  • Lim HK, Cho SJ, Baek JH, et al. US-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: efficacy and safety in a large population. Korean J Radiol. 2019;20(12):1653–1661.
  • Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid. 2016;26(11):1581–1587.
  • Xiao J, Zhang M, Zhang Y, et al. Efficacy and safety of ultrasonography-guided radiofrequency ablation for the treatment of T1bN0M0 papillary thyroid carcinoma: a retrospective study. Int J Hyperthermia. 2020;37(1):392–398.
  • Wu R, Luo Y, Tang J, et al. Ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma: a retrospective analysis of 198 patients. Int J Hyperthermia. 2020;37(1):168–174.
  • Sung JY, Baek JH, Jung SL, et al. Radiofrequency ablation for autonomously functioning thyroid nodules: a multicenter study. Thyroid. 2015;25(1):112–117.
  • Mazzaferri EL, Massoll L. Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin. Endocr Relat Cancer. 2002;9(4):227–247.
  • Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. U.S. and German thyroid cancer study group. An American College of Surgeons Commission on cancer patient care evaluation study. Cancer. 2000;89(1):202–217.
  • Biondi B, Cooper DS. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid. 2010;20(2):135–146.
  • Zhang M, Tufano RP, Russell JO, et al. Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years' follow-up. Thyroid. 2020;30(3):408–417.
  • Sugitani I, Toda K, Yamada K, et al. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg. 2010;34(6):1222–1231.
  • Miyauchi A, Ito Y, Oda H. Insights into the management of papillary microcarcinoma of the thyroid. Thyroid. 2018;28(1):23–31.
  • Recognition and challenge of thyrotropin inhibition therapy after thyroid microcarcinoma. Chinese J Pract Surg. 2016;36(05):524–527.